386 related articles for article (PubMed ID: 30744584)
1. Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort study.
Mandese V; Bigi E; Bruzzi P; Palazzi G; Predieri B; Lucaccioni L; Cellini M; Iughetti L
BMC Pediatr; 2019 Feb; 19(1):56. PubMed ID: 30744584
[TBL] [Abstract][Full Text] [Related]
2. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
[TBL] [Abstract][Full Text] [Related]
3. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study.
Soliman AT; elZalabany M; Amer M; Ansari BM
J Trop Pediatr; 1999 Feb; 45(1):23-30. PubMed ID: 10191589
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
Fung EB; Harmatz PR; Lee PD; Milet M; Bellevue R; Jeng MR; Kalinyak KA; Hudes M; Bhatia S; Vichinsky EP;
Br J Haematol; 2006 Nov; 135(4):574-82. PubMed ID: 17054676
[TBL] [Abstract][Full Text] [Related]
5. Vitamin B6 status of children with sickle cell disease.
Nelson MC; Zemel BS; Kawchak DA; Barden EM; Frongillo EA; Coburn SP; Ohene-Frempong K; Stallings VA
J Pediatr Hematol Oncol; 2002; 24(6):463-9. PubMed ID: 12218594
[TBL] [Abstract][Full Text] [Related]
6. Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease.
Asnani MR; Fraser RA; Reid ME
PLoS One; 2011 Apr; 6(4):e18863. PubMed ID: 21533141
[TBL] [Abstract][Full Text] [Related]
7. Growth and nutritional status of children with homozygous sickle cell disease.
Al-Saqladi AW; Cipolotti R; Fijnvandraat K; Brabin BJ
Ann Trop Paediatr; 2008 Sep; 28(3):165-89. PubMed ID: 18727846
[TBL] [Abstract][Full Text] [Related]
8. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).
Dalibalta S; Ellory JC; Browning JA; Wilkins RJ; Rees DC; Gibson JS
Blood Cells Mol Dis; 2010 Jun; 45(1):46-52. PubMed ID: 20227897
[TBL] [Abstract][Full Text] [Related]
9. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
10. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
11. Osteopenia and vitamin D deficiency in children with sickle cell disease.
Chapelon E; Garabedian M; Brousse V; Souberbielle JC; Bresson JL; de Montalembert M
Eur J Haematol; 2009 Dec; 83(6):572-8. PubMed ID: 19682065
[TBL] [Abstract][Full Text] [Related]
12. Effects of nutritional intake on disease severity in children with sickle cell disease.
Mandese V; Marotti F; Bedetti L; Bigi E; Palazzi G; Iughetti L
Nutr J; 2016 Apr; 15(1):46. PubMed ID: 27130184
[TBL] [Abstract][Full Text] [Related]
13. Growth in children and adolescents with sickle cell disease in Yemen.
Al-Saqladi AW; Bin-Gadeen HA; Brabin BJ
Ann Trop Paediatr; 2010; 30(4):287-98. PubMed ID: 21118622
[TBL] [Abstract][Full Text] [Related]
14. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
[TBL] [Abstract][Full Text] [Related]
15. Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).
da Guarda CC; Yahouédéhou SCMA; Santiago RP; Neres JSDS; Fernandes CFL; Aleluia MM; Figueiredo CVB; Fiuza LM; Carvalho SP; Oliveira RM; Fonseca CA; Ndidi US; Nascimento VML; Rocha LC; Goncalves MS
PLoS One; 2020; 15(1):e0228399. PubMed ID: 31995624
[TBL] [Abstract][Full Text] [Related]
16. Body Mass Index and the Association With Vaso-occlusive Crises in Pediatric Sickle Cell Disease.
Zivot A; Apollonsky N; Gracely E; Raybagkar D
J Pediatr Hematol Oncol; 2017 May; 39(4):314-317. PubMed ID: 28221266
[TBL] [Abstract][Full Text] [Related]
17. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
Soliman AT; Yassin MA; De Sanctis V
Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
19. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
20. Frequency and risk factors of endocrine complications in Turkish children and adolescents with sickle cell anemia.
Ozen S; Unal S; Erçetin N; Taşdelen B
Turk J Haematol; 2013 Mar; 30(1):25-31. PubMed ID: 24385749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
